Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 0 | $0 |
Sells | 16 | $128,798 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
22 Feb 2024 20:19 | NKTR | NEKTAR THERAPEUTICS | ZALEVSKY JONATHAN | Chief R&D Officer | 20 Feb 2024 | Sale | 9,014 | 0.68 | 6,130 | D |
22 Feb 2024 20:17 | NKTR | NEKTAR THERAPEUTICS | WILSON MARK ANDREW | Chief Legal Officer | 20 Feb 2024 | Sale | 7,606 | 0.68 | 5,172 | D |
22 Feb 2024 20:16 | NKTR | NEKTAR THERAPEUTICS | ROBIN HOWARD W | President & CEO | 20 Feb 2024 | Sale | 20,033 | 0.68 | 13,622 | D |
20 Nov 2023 21:02 | NKTR | NEKTAR THERAPEUTICS | ZALEVSKY JONATHAN | Chief R&D Officer | 17 Nov 2023 | Sale | 9,646 | 0.49 | 4,727 | D |
20 Nov 2023 21:00 | NKTR | NEKTAR THERAPEUTICS | WILSON MARK ANDREW | Chief Legal Officer | 17 Nov 2023 | Sale | 7,179 | 0.49 | 3,518 | D |
20 Nov 2023 20:58 | NKTR | NEKTAR THERAPEUTICS | ROBIN HOWARD W | President & CEO | 17 Nov 2023 | Sale | 19,877 | 0.49 | 9,740 | D |
20 Sep 2023 20:09 | NKTR | NEKTAR THERAPEUTICS | CURET MYRIAM | Director | 18 Sep 2023 | Sale | 4,359 | 0.69 | 3,008 | D |
20 Sep 2023 20:08 | NKTR | NEKTAR THERAPEUTICS | CHESS ROBERT | Director | 22 Sep 2022 | Sale | 10,200 | 0.67 | 6,834 | D |
20 Sep 2023 20:06 | NKTR | NEKTAR THERAPEUTICS | AJER JEFFREY ROBERT | Director | 18 Sep 2023 | Sale | 4,359 | 0.69 | 3,008 | D |
17 Aug 2023 20:08 | NKTR | NEKTAR THERAPEUTICS | ZALEVSKY JONATHAN | Chief R&D Officer | 16 Aug 2023 | Sale | 9,703 | 0.78 | 7,568 | D |
17 Aug 2023 20:07 | NKTR | NEKTAR THERAPEUTICS | WILSON MARK ANDREW | Chief Legal Officer | 16 Aug 2023 | Sale | 7,221 | 0.78 | 5,632 | D |
17 Aug 2023 20:06 | NKTR | NEKTAR THERAPEUTICS | ROBIN HOWARD W | President & CEO | 16 Aug 2023 | Sale | 19,998 | 0.78 | 15,598 | D |
15 Jun 2023 18:26 | NKTR | NEKTAR THERAPEUTICS | WHITFIELD ROY A | Director | 14 Jun 2023 | Sale | 30,000 | 0.57 | 17,100 | D |
17 May 2023 20:29 | NKTR | NEKTAR THERAPEUTICS | ZALEVSKY JONATHAN | Chief R&D Officer | 16 May 2023 | Sale | 9,791 | 0.72 | 7,050 | D |
17 May 2023 20:28 | NKTR | NEKTAR THERAPEUTICS | WILSON MARK ANDREW | Chief Legal Officer | 16 May 2023 | Sale | 7,543 | 0.72 | 5,431 | D |
17 May 2023 20:27 | NKTR | NEKTAR THERAPEUTICS | ROBIN HOWARD W | President & CEO | 16 May 2023 | Sale | 20,361 | 0.72 | 14,660 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)